课题基金 / 基金详情

项目摘要

项目成果

Takeshi Egawa的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Abstract In response to viral infection or vaccination, antigen(Ag)-specific CD8 T cells that are present at low frequencies undergo rapid clonal expansion. While the majority of activated CD8 T cells become terminally differentiated effector T (TEFF) cells following expansion and die after Ag clearance, a small fraction of them persists as memory cells (TMEM) that contribute to long-term protection. However, it remains incompletely understood how cell-extrinsic stimuli through TCR and cytokine receptors establish the gene regulatory networks that determine the fates of activated CD8 T cells. The overall goal of this grant is to dissect the molecular and cellular mechanisms by which TCR and IL-2R signaling cooperatively regulates CD8 T cell differentiation through the control of the critical transcription factor TCF-1 encoded by Tcf7. We will test the hypothesize that cooperative action between signals induced by antigen and IL-2, but not IL-15, specifically during priming induces expression of a set of transcription factors and epigenetic changes at a transcriptional silencer element in the Tcf7 locus. The establishment of stable Tcf7 repression requires the stimulation- responsive enhancement of IL-2R signaling, which establishes steady the TEFF- or TMEM-specific gene regulatory circuitry that can be stably maintained after the inducing cell extrinsic stimuli decays as immune responses resolve or become equilibrated. These studies will provide insights into the long standing question of the molecular mechanisms of CD8 T cell differentiation and potential application to programming improved immunotherapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of a novel mouse model with progesterone-independent susceptibility to genital HSV infection
  • 批准号:
    10615599
  • 项目类别:
  • 资助金额:
    $7.8万
  • 财政年份:
    2022
  • 负责人:
    Takeshi Egawa
  • 依托单位:
Development of a novel mouse model with progesterone-independent susceptibility to genital HSV infection
  • 批准号:
    10352920
  • 项目类别:
  • 资助金额:
    $7.88万
  • 财政年份:
    2022
  • 负责人:
    Takeshi Egawa
  • 依托单位:
Identification of progenitor CD4 T cells that support response to chronic antigen
  • 批准号:
    10449403
  • 项目类别:
  • 资助金额:
    $19.69万
  • 财政年份:
    2021
  • 负责人:
    Takeshi Egawa
  • 依托单位:
Identification of progenitor CD4 T cells that support response to chronic antigen
  • 批准号:
    10316709
  • 项目类别:
  • 资助金额:
    $23.63万
  • 财政年份:
    2021
  • 负责人:
    Takeshi Egawa
  • 依托单位:
海外基金